(Q28299852)

2

0 references

author name string

Alessandro Gubbini

3

0 references

Silvia Battistacci

4

0 references

Fiorenzo Conti

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

5

0 references

language of work or name

English

0 references

publication date

May 2009

0 references

published in

Glia

0 references

volume

57

0 references

issue

7

0 references

page(s)

703-13

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

Sensorimotor gating and schizophrenia. Human and animal model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Schizophrenia: the fundamental questions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Amoxacillin-induced psychosis?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Disruption of prepulse inhibition in mice lacking mGluR1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Shaping excitation at glutamatergic synapses

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The GABA-glutamate connection in schizophrenia: which is the proximate cause?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

https://api.crossref.org/works/10.1002%2FGLIA.20798

1 reference

7 January 2021

Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The behavior of APO-SUS rats in animal models with construct validity for schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

GLT-1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Mouse genetic models for prepulse inhibition: an early review

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Acute psychotic reactions and stress response syndromes following intramuscular aqueous procaine penicillin

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Intracellular modulation of NMDA receptor function by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Pathophysiologically based treatment interventions in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Neuroprotective potential of ceftriaxone in in vitro models of stroke.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Cephalosporin-Induced Psychosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Disorders of attention and perception in early schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Synaptic localization of GLT-1a in the rat somatic sensory cortex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Light microscopic identification and immunocytochemical characterization of glutamatergic synapses in brain sections

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Penicillin psychosis in later life: Hoigne's syndrome revisited.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Daily variations in ceftriaxone pharmacokinetics in rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Localization of neuronal and glial glutamate transporters

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Shared gene expression alterations in schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Schizophrenia and the mechanisms of conscious integration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Glutamate and monoamine transporters: new visions of form and function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Glutamate transporters: confining runaway excitation by shaping synaptic transmission

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

The effect of auditory and visual stimulation on the skin potential response of schizophrenics.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20798

7 January 2021